Français
ItalianoBond Boston Medica 2.85% ( US101137AP29 ) in USD
| Issuer | Boston Medica |
| Market price | 100.15 % ▲ |
| Country |  United States
|
| ISIN code |
 US101137AP29 ( in USD )
|
| Interest rate | 2.85% per year ( payment 2 times a year) |
| Maturity | 15/05/2020 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 600 000 000 USD |
| Cusip | 101137AP2 |
| Detailed description |
Boston Scientific is a global medical device company that develops, manufactures, and sells medical devices used in interventional medicine and chronic diseases. A detailed analysis of a recently matured bond issued by Boston Scientific, a leading global medical technology corporation renowned for developing and manufacturing a broad range of innovative medical solutions, offers a clear financial snapshot. This specific fixed-income instrument, distinguished by ISIN US101137AP29 and CUSIP 101137AP2, originated from the United States market. The bond's core specifications included a total issuance size of $600,000,000, denominated in United States Dollars (USD), with a minimum investment threshold of $2,000 per purchase. Throughout its active period, this bond carried an annual interest rate of 2.85%, with payments scheduled semi-annually, and was notably observed trading at 100.15% of its par value in the secondary market. Its lifecycle concluded precisely on May 15, 2020, when the obligation reached its full maturity and was subsequently repaid in its entirety to bondholders, signifying the successful completion of this financial instrument's term. |